Children with Eczema Struggle More with Comorbid ADHD Symptoms
New data suggest children with atopic dermatitis and comorbid ADHD are nearly 3 times more likely to struggle with memory compared to those with just ADHD.
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Data show significant maternal and fetal risks in cases when pregnant women are diagnosed with hidradenitis suppurativa. A researcher discusses opportunities to learn more.
Analysis: Pediatric Isotretinoin Use Not Linked to Shorter Adult Height
Isotretinoin was actually linked to a taller adult height among those who took it to treat acne in childhood versus doxycycline, in a new study.
Pediatric Contact Dermatitis Allergens Vary by Age, Sex, Race
New data show sensitization among children with allergic contact dermatitis may be significantly influenced by their age and gender, among other demographic details.
Children with Atopic Dermatitis May Be Shorter in Height
New global data suggest children with moderate to severe atopic dermatitis may experience stunted growth due to the effect of their disease on sleep, as well as use of certain therapies.
Pediatric Hidradenitis Suppurativa Severity not Linked to Obesity
New data from the Mayo Clinic show high BMI does not correlate with severe hidradenitis suppurativa in affected children and adolescents.
Ruxolitinib Cream Improves Itch, Sleep, Skin Pain in Children with Atopic Dermatitis
A secondary analysis from TRuE-AD3 shows ruxolitinib cream significantly benefits pediatric atopic dermatitis patient-reported outcomes.
Preservative, Surfactant Allergens Frequently Found in Infant Skincare Products
Data presented at AAD 2024 hopes to clarify allergen exposure risks during infancy that may increase risk of allergic contact dermatitis.
Maternal Hidradenitits Suppurativa Linked to Neonatal Mortality, Pediatric Hospitalization Risk
A national cohort analysis presented at AAD 2024 showed a significant link between maternal HS exposure and poor health outcomes among children.
Breakthroughs in Pediatric Atopic Dermatitis and More, with Peter A. Lio, MD
Lio reviews a field now teeming with FDA-approved options and candidates throughout early-age eczema, psoriasis and more.
Clinical Quiz: Diagnosing Epidermolysis Bullosa
Take our latest 5-question quiz based on the recommended strategies of laboratory-based diagnosis of epidermolysis bullosa.
Black Pediatric Patients with Hidradenitits Suppurativa Report Worse Income Status, Health Risks
New data presented at AAD 2024 highlights challenges in financial status, insurance and comorbidities among black pediatric patients with HS.
Nanette B. Silverberg, MD: Uncovering Molluscum Epidemiology
With a couple of first-time therapies available for molluscum, Silverberg is interested in learning more about the disease's causes and manifestations.
Amy Paller, MD: Long-Term Outlook for EB, Ichthyosis and Netherton Syndrome Treatment
With drug breakthroughs reaching epidermolysis bullosa, Paller considers what may come next for other rare skin diseases.
3 Tried and True Methods of Pediatric Eczema Management
Lawrence Eichenfield, MD, reviews prescription and at-home care strategies for pediatric atopic dermatitis, as well as the best measures of disease monitoring.
Clinical Quiz: Methotrexate for Pediatric Dermatoses
In recognition of the Pre-AAD 2024 meeting, take our quiz based on Society for Pediatric Dermatology resources.
Celebrating 30 Years of Camp Discovery, with Susan Boiko, MD
Boiko discusses the annual weeklong summer camp for children and adolescents with skin diseases to make connections, experience camp with the support of volunteer specialists, and find comfort with their condition.
How Gene and Cell Therapy Is Developing in Dermatology
Peter Marinkovich, MD, reflects on the significant growth in advanced therapy development, particularly in rare skin diseases.
Reviewing New Molluscum Therapies, with Nanette B. Silverberg, MD
The FDA approved the first 2 therapies to treat molluscum contagiosum in the last year. Silver explains how it's provided more than just treatment options.
Gene, Cell Therapies and Advanced Rare Disease Talk at AAD 2024
Joyce Teng, MD, PhD, discusses how therapeutic advances in fields like epidermolysis bullosa should progress treatment discourse in other rare dermatoses.
The Prospect of Pz-cel in RDEB Treatment, with Peter Marinkovich, MD
Marinkovich discusses how the investigative cell-based graft therapy may serve a key role in the emerging DEB treatment paradigm.
Clinical Quiz: Pediatric Acne Treatment Recommendations
Peter Lio, MD: Minimizing Painful Pediatric Dermatologic Procedures
Lio shares 3 aspects of pain management that dermatologists can consider to improve the experience of procedures for patients.
Comparing New Therapies for Dystrophic Epidermolysis Bullosa
Joyce Teng, MD, PhD, reviews a pair of recently approved agents for DEB—as well as a cell therapy awaiting FDA decision this year.
Amy Paller, MD: What Pz-cel, B-VEC Each Bring to Recessive DEB
Gene and cell therapies are reaching patients with the severe forms of epidermolysis bullosa. An expert explains their differing benefits and strengths.
Caitlin Treuting: Medical Photography Grows in Pediatric Dermatology
Beyond the obvious benefits, the practice of remote and in-clinic photography is altering treatment capabilities.
Alberto Pappo, MD: Why Pediatric Melanoma Diagnosis Is In Flux
The St. Jude oncologist discusses the 30-year development of pediatric melanoma interpretation.
Karan Lal, DO, MS, FAAD: Ruxolitinib Cream a "True Medical Breakthrough" for Vitiligo
Dr. Karan Lal speaks on treating vitiligo in patients from across the world, and how he expects a wave of prescription requests for ruxolitinib cream following the potential FDA approval.
